Aharon Gil
Transaction: 04/28/2026
BUY
Change
+12,304
Price
Not reported
Filing
04/30/2026
Type
BUY
NeurAxis, Inc.
NRXS • Biotechnology
$5.96
▼ -0.11 (-1.81%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$72.23M
Growth
1.8%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.12Healthy liquidity · 2.05Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 13, 2026, 12:20 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$5.96
Change-1.81%
Shares Out12.12M
Market Cap$72.23M
Enterprise Value$64.03M
52W Range2.21 - 9.33
Beta1.47
P/E-9.41
P/S13.59
P/B10.73
P/FCF-12.82
EV/Sales12.04
Price$5.96
Change-1.81%
Shares Out12.12M
Market Cap$72.23M
Enterprise Value$64.03M
52W Range2.21 - 9.33
Beta1.47
P/E-9.41
P/S13.59
P/B10.73
P/FCF-12.82
EV/Sales12.04
EV/EBITDA-8.43
EV/FCF-11.37
Earnings Yield-10.63%
FCF Yield-7.80%
Dividend Yield0.00%
Gross Margin84.23%
Oper. Margin-2.19%
Profit Margin-2.19%
Debt/Eq0.12
Current Ratio2.05
Quick Ratio1.96
Revenue 5Y1.85%
Target$8.00
Target Upside34.23%
Target Median$8.00
Target Range8.00 - 8.00
Volume152.13K
Avg Volume127.09K
EPS Surprise0.01
Investment DNA
How strong this company looks for long-term investors
29
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Manageable debt level · 0.12Healthy liquidity · 2.05Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 1 analyst votes · 2026-09-05
100/100
Bullish
Bullish
1
Hold
0
Bearish
0
Price Target
2026-08-13
Low
$8.00
Mean
$8.00
Median
$8.00
High
$8.00
Insider Transactions
Recent executive and insider activity
Carrico Brian Allen
Transaction: 04/01/2026
BUY
Change
+8,060
Price
$1.96
Filing
04/03/2026
Type
BUY
Carrico Thomas Joeseph
Transaction: 04/01/2026
BUY
Change
+667
Price
$1.96
Filing
04/03/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Aharon Gil | BUY | +12,304 | Not reported | 04/28/2026 | 04/30/2026 |
| Carrico Brian Allen | BUY | +8,060 | $1.96 | 04/01/2026 | 04/03/2026 |
| Carrico Thomas Joeseph | BUY | +667 | $1.96 | 04/01/2026 | 04/03/2026 |
| Henrichs Timothy Robert | BUY | +7,593 | $1.96 | 04/01/2026 | 04/03/2026 |
| Miranda Adrian | BUY | +47,569 | Not reported | 01/22/2026 | 03/02/2026 |
| Carrico Brian Allen | BUY | +94,173 | Not reported | 01/22/2026 | 02/26/2026 |
| Carrico Thomas Joeseph | BUY | +47,569 | Not reported | 01/22/2026 | 02/26/2026 |
| Henrichs Timothy Robert | BUY | +75,231 | Not reported | 01/22/2026 | 02/26/2026 |
| Keyser Jane Elizabeth | BUY | +21,598 | $4.63 | 01/22/2026 | 02/26/2026 |
| Watkins Bradley Mitchell | BUY | +21,598 | $4.63 | 01/22/2026 | 02/26/2026 |
| Ferge Kristin A | BUY | +21,598 | $4.63 | 01/22/2026 | 01/30/2026 |
| Aharon Gil | BUY | +21,598 | $4.63 | 01/22/2026 | 01/30/2026 |
| Aharon Gil | BUY | +286,138 | $3.52 | 12/23/2025 | 12/29/2025 |
| Henrichs Timothy Robert | BUY | +8,037 | Not reported | 03/18/2025 | 09/10/2025 |
| Carrico Thomas Joeseph | BUY | +10,000 | Not reported | 03/04/2025 | 09/10/2025 |
| Miranda Adrian | BUY | +10,000 | Not reported | 03/04/2025 | 09/10/2025 |
| Henrichs Timothy Robert | BUY | +66,000 | Not reported | 03/04/2025 | 09/10/2025 |
| Carrico Brian Allen | BUY | +10,000 | Not reported | 03/04/2025 | 09/10/2025 |
| Watkins Bradley Mitchell | BUY | +13,157 | $2.85 | 01/17/2025 | 09/10/2025 |
| Keyser Jane Elizabeth | BUY | +13,157 | $2.85 | 01/17/2025 | 09/10/2025 |